Karen Drexler

Karen Drexler is a seasoned executive and board member with extensive experience in healthcare, medical devices, and digital health. She has been serving as a Member of the Board of Directors at Huma.AI since April 2022.1 Huma.AI is a company that uses machine learning to simplify the interrogation of complex healthcare data sets.2

Drexler's career highlights include:

1. Board positions: She currently serves on the boards of several companies, including ResMed (NYSE: RMD, ASX: RMD), Outset Medical (NASDAQ: OM), and EBR Systems (ASX: EBR).13

2. CEO experience: Drexler was the CEO of Sandstone Diagnostics, Inc. from 2016 to 2020.1

3. Entrepreneurship: She has founded and led multiple companies, including Amira Medical Inc., which was sold to Roche Holding AG in 2001.3

4. Education: Drexler holds a BSE in Chemical Engineering from Princeton University and an MBA from Stanford University Graduate School of Business.3

5. Advocacy: She is an active mentor and advisor for early-stage companies, particularly those led by women, through organizations like Astia, StartX, and Springboard.3

Drexler's expertise spans various healthcare sectors, including digital health, medical devices, diagnostics, and AI applications in life sciences.123